Biology Becomes Information Technology

Q: What does Ray Kurzweil mean by 'biology becomes information technology'?

Kurzweil's argument, central to his 'law of accelerating returns,' is that once any field can be expressed as digital information, it begins improving at an exponential rate because each generation of tools helps design the next. He points to genomics: once DNA could be read and written as a digital code of base pairs processed by computers, biology became subject to the same exponential price-performance gains seen in computing. In his framing, the genome is the 'software' of life, and decoding and reprogramming it becomes an information-technology problem rather than a purely wet-lab one.

Q: What was Kurzweil's point about the Human Genome Project being 'halfway done' at 1 percent?

Roughly halfway through the 15-year Human Genome Project, only about 1 percent of the genome had been sequenced, and many observers declared it a failure, reasoning it would take centuries to finish. Kurzweil argued the opposite: because sequencing output was doubling roughly every year, 1 percent was only about seven doublings from 100 percent, so the project was effectively halfway there in the terms that mattered. The project was indeed completed close to its target, finishing in April 2003. Kurzweil uses this repeatedly to illustrate how people mistake the early, flat part of an exponential curve for failure.

Q: How much has the cost of sequencing a human genome actually fallen?

The Human Genome Project's first reference sequence, completed in 2003, cost on the order of hundreds of millions to billions of dollars across the full effort (the project's total was about $2.7 billion in FY 1991 dollars). The U.S. National Human Genome Research Institute, which tracks per-genome cost, documents a drop far faster than Moore's Law after 2007, when next-generation sequencing arrived. By the early 2020s the cost of sequencing a human genome had fallen to roughly $1,000 or less, a decline of several orders of magnitude that is often cited as evidence for Kurzweil's thesis.

Q: Where does this idea appear in Kurzweil's work?

The concept is developed in Kurzweil's 2005 book 'The Singularity Is Near: When Humans Transcend Biology' and in his earlier essay 'The Law of Accelerating Returns' (2001). There he lays out the 'GNR' revolutions—Genetics, Nanotechnology, and Robotics (AI)—as overlapping waves that will transform the human condition. The genetics revolution, in his telling, is the point at which biology becomes an information technology we can read, debug, and rewrite. These are explicitly his projections and arguments, not settled scientific consensus.

Q: Do scientists agree with Kurzweil's predictions about reprogramming biology?

Kurzweil's track record on the exponential decline in sequencing cost is widely acknowledged, and the digitization of genomics is real. However, his broader predictions—that we will soon reverse aging, eliminate most disease through gene therapies, and merge biology with nanotechnology on his stated timelines—remain contested projections rather than established outcomes. Critics, including some biologists and commentators in venues like Science, argue that biology's complexity (gene regulation, protein folding, multi-system interactions) does not reduce as cleanly to an information-technology exponential as raw sequencing cost does. These claims should be read as documented forecasts, not facts.

Q: Why does Kurzweil treat genome sequencing as proof of the law of accelerating returns?

For Kurzweil, sequencing is a clean case study because it converts a biological process into a measurable, digital one whose cost and throughput can be charted over time. The roughly annual doubling in sequencing capacity during the Human Genome Project, and the steep post-2007 cost collapse, fit the smooth exponential curve his law predicts. He uses it to make a general claim: that once a technology becomes informational, linear intuition badly underestimates future progress. Whether that pattern generalizes to curing aging or building molecular nanobots is a separate, still-open question.

2003–2026 CE · Deep-Dive Event Pages · critical-turning-points

The human genome went from $2.7 billion to $100. Biology is now software.

Explore this event on the interactive timeline →

Kurzweil predicted in 2005 that once biology became an "information technology," its costs would collapse exponentially — faster than even Moore's Law. The Human Genome Project proved him spectacularly right: the cost of sequencing a human genome dropped from $2.7 billion in 2003 to approximately $100 in 2026. That is 24.7 halvings in 23 years — a halving rate of 11.2 months, obliterating Moore's Law pace.

Key Numbers

HGP duration: 13 years (1990-2003)
Total project cost: $2.7 billion (FY1991 dollars)
Sequenced at halfway point: ~1% of genome
Cost-per-genome drop: ~$95M (2001) to <$1,000 (2019)
Sequencing vs Moore's Law: Fell far faster than Moore's Law

Verified Facts

Ray Kurzweil repeatedly cites the Human Genome Project as his showcase example of the Law of Accelerating Returns, his thesis that information technologies improve at an exponential, not linear, rate -- which he frames as the moment biology itself became an information technology.
Kurzweil's central anecdote: roughly halfway through the project's 15-year timeline, critics declared it a failure because only about 1% of the genome had been sequenced -- but Kurzweil argued that at the observed annual doubling rate, 1% was only about seven doublings away from 100%, so the project was actually nearly on track and finished on schedule.
The argument is documented in Kurzweil's 2005 book 'The Singularity Is Near: When Humans Transcend Biology,' where he generalizes the genome case into his claim that exponential trends look deceptively slow in early stages before accelerating dramatically.
The Human Genome Project ran from 1990 to 2003 and was completed by the International Human Genome Sequencing Consortium, with completion formally announced on April 14, 2003 -- more than two years ahead of its planned 2005 finish.
The project cost roughly $2.7 billion in FY1991 dollars, coming in under the ~$3 billion that the U.S. Congress was originally told it would require, validating Kurzweil's point that exponential progress outpaced pessimistic linear cost projections.
The completion was published in the April 24, 2003 issue of Nature, timed to the 50th anniversary of Watson and Crick's 1953 double-helix paper -- and the final sequence accounted for roughly 92% of the human genome with fewer than 400 gaps.
The cost to sequence a human genome collapsed from about $95-100 million in 2001 (the NHGRI tracking baseline) to a few thousand dollars within two decades, a decline of roughly five orders of magnitude that, by NHGRI's own accounting, fell faster than Moore's Law would predict.
A key inflection occurred in 2008 with the commercial rollout of next-generation (massively parallel) sequencing replacing Sanger sequencing: per-genome cost dropped from around $3 million early in the year toward the high hundreds of thousands by year-end -- the steepest single-year fall in the NHGRI dataset.
Illumina announced the HiSeq X Ten system in January 2014, marketed as the first platform to break the '$1,000 genome' barrier for a 30x human genome; by NHGRI's fuller cost accounting (including labor and overhead) the real per-genome cost crossed below $1,000 around 2019.
Caveat for honest framing: Kurzweil's interpretation is a documented retrospective argument, and historians note the HGP's acceleration also owed much to specific institutional decisions, the public-vs-private (Celera) sequencing race, and the arrival of new sequencing machines -- not solely to a smooth, inevitable exponential curve, so the 'pure doubling' narrative is a simplification.

The World at This Moment

The reframing of biology as information technology matured at the millennium's turn. On 26 June 2000, Bill Clinton and Tony Blair jointly announced a working draft of the human genome, a public consortium (Francis Collins, NIH/DOE) racing Craig Venter's Celera; the near-complete sequence followed in April 2003, coinciding with DNA's fiftieth anniversary. This unfolded amid the dot-com bust (the NASDAQ peaked March 2000), the post-9/11 security turn, and the early Web 2.0 buildout. Moore's Law still governed expectations of exponential progress in silicon. In genomics, Sanger sequencing dominated until next-generation platforms (Solexa/Illumina, 454) arrived around 2005-2008, triggering the steep cost decline. Bioinformatics, GenBank, and the BLAST algorithm had already recast genes as searchable data. Kurzweil, fresh from The Age of Spiritual Machines (1999), published "The Law of Accelerating Returns" in 2001 and The Singularity Is Near in 2005, situating genomics within a sweeping claim that all information technologies—not just computing—advance exponentially in price-performance.

The Paradigm Shift

Kurzweil's contribution was conceptual rather than experimental: he generalized Moore's Law beyond semiconductors into a "Law of Accelerating Returns" and argued that once a domain becomes an information technology, it inherits exponential price-performance growth. Genomics was his proof case. Where the Human Genome Project had cost roughly $3 billion and a decade, sequencing cost-per-genome then fell from about $95 million in 2001 to under $1,000 by the late 2010s—outpacing Moore's Law itself, especially after next-generation sequencing arrived around 2008. This recast DNA not as chemistry but as readable, writable, hackable code: the "software of life." The framing licensed synthetic biology, personalized genomic medicine, and ultimately the logic that biology could be engineered and accelerated like software. It also became foundational to Singularitarian thought, supplying empirical-seeming curves to claims that biotechnology, nanotechnology, and AI would converge toward radical life extension and machine superintelligence—shifting these from science fiction into a forecast many technologists took as a planning horizon.

In Their Own Words

"When the genome project was first announced, skeptics said, 'You'll never get this done.' Halfway through the fifteen-year project, only 1 percent had been collected, so the skeptics were going strong. But the project had been doubling every year, and 1 percent is only seven doublings from 100 percent. It was indeed completed seven years later." — Ray Kurzweil, recounting the Human Genome Project as an illustration of the Law of Accelerating Returns (a point he makes in The Singularity Is Near, 2005, and repeats in interviews and his MIT Technology Review reply "Don't Underestimate the Singularity," 2011)

In Depth

The Genome as Software: When Life Became Legible

For nearly four billion years, the central drama of life on Earth was the silent operation of a code no one could read. The instructions that distinguished a bacterium from a redwood from a human were written in DNA, but they ran the way machine language runs on a chip with no debugger — executed, never inspected. Ray Kurzweil's claim that "biology becomes information technology" marks the moment that situation inverted. Once the genome could be read, written, and copied as data, life ceased to be only a substance and became, in part, a file format. This is less a single dated event than a threshold crossing, and Kurzweil's framing — drawn out across The Singularity Is Near (sv-singularity-near) — is that the crossing obeys the same exponential logic he calls the Law of Accelerating Returns (sv-kurzweil-law).

The Deep Precondition: A Code That Predates the Reader

The thesis only makes sense because life was already digital long before any human noticed. The four-letter nucleotide alphabet is a genuine information system, laid down at the Origin of Life (sv-origin-of-life) and elaborated across every later innovation in the biological story — the metabolic rewiring of the Great Oxygenation Event (sv-great-oxygenation), the modular complexity of the First Complex Cells (sv-first-complex-cells), and the recombinational gene-shuffling unleashed by the Invention of Sexual Reproduction (sv-invention-of-sex). Evolution, in Kurzweil's reading, is itself an information-processing algorithm — slow, blind, but accumulating. What changed with the Human Genome Project was not that biology became information, but that humans finally gained read-access to a repository written by Charles Darwin's mechanism of descent with modification (sv-charles-darwin).

The Exponential Proof

Kurzweil's favorite illustration is the Genome Project itself. Launched in 1990 as a fifteen-year, multi-billion-dollar effort, it had sequenced only about 1 percent of the genome by 1997 — halfway through its schedule. Critics declared it a failure: at that rate, completion lay seven centuries away. Kurzweil's response was that 1 percent, with capacity doubling annually, meant the project was effectively halfway done — seven doublings from completion. It finished in 2003, on time. The cost curve that followed is among the steepest in the history of technology: roughly a billion dollars per genome in 2003 collapsing toward a thousand dollars within two decades, a millionfold drop that outpaced Moore's Law itself. This is the empirical spine of the claim — the same exponential signature that connects the deep past to the projected future.

What It Reshaped

Treating biology as a manipulable medium reframes every Kurzweilian prediction downstream. If the genome is software, then aging and disease are, in principle, debuggable — the conceptual foundation of Longevity Escape Velocity (sv-kurzweil-lev), where medical progress outruns the clock. It makes the body a target for engineered intervention, pointing toward the molecular machinery of Nanobots & Full-Dive VR (sv-kurzweil-nanobots). And it dissolves the old boundary between the born and the built: once life is editable information, the merger of biological and non-biological intelligence that defines The Singularity (sv-kurzweil-singularity) becomes a difference of degree, not of kind.

Threads Forward and Back

The deeper resonance is that this event reframes the entire arc behind it. The same mathematics of accelerating returns that compressed genome sequencing also drove the digital substrate — the World Wide Web (sv-www) as a planetary information layer, and the pattern-recognition leap of AlexNet & the Deep Learning Revolution (sv-alexnet-convnets) that gave machines the ability to read genomic and proteomic data at superhuman scale. In Kurzweil's grand narrative, the moment biology becomes information technology is the hinge where the story of carbon and the story of computation stop running on separate tracks. It is worth holding honestly as a documented prediction-framework rather than settled fact — but its central observation, that we can now read and edit the oldest code on Earth, is no longer speculative at all.

Causes & Consequences

What led to it

Watson and Crick's 1953 description of the DNA double helix recast genes as a 'code' that carries information, introducing the framing of life as something written in a discrete molecular alphabet (A, T, C, G).
The mid-20th-century rise of Shannon information theory and cybernetics supplied the conceptual vocabulary of 'code,' 'information,' and 'transcription' that molecular biologists adopted to describe how DNA stores and transmits instructions.
Gordon Moore's 1965 observation that transistor counts double roughly every two years gave Kurzweil the empirical template for exponential progress that he later generalized into his 'Law of Accelerating Returns.'
The Human Genome Project, launched in 1990 and completed in 2003 at a cost of roughly 2.7 billion dollars, produced the first full digital reference sequence of human DNA and proved that an entire genome could be rendered as computer-readable data.
The development of next-generation (massively parallel) sequencing platforms and competition among companies like Illumina drove the cost of sequencing a human genome down from hundreds of millions of dollars to about 1,000 dollars by 2014, a steep exponential decline that exemplified Kurzweil's thesis.
Kurzweil's own books, especially 'The Age of Spiritual Machines' (1999) and 'The Singularity Is Near' (2005), articulated the explicit argument that once any field becomes an information technology it falls under the Law of Accelerating Returns, applying this directly to genomics.

What it set in motion

Treating the genome as software enabled J. Craig Venter's team in 2010 to build the first self-replicating bacterial cell controlled by a chemically synthesized genome, which Venter described as the first organism 'whose parent is a computer.'
The reconception of DNA as programmable information underpinned the 2012 CRISPR-Cas9 work of Jennifer Doudna and Emmanuelle Charpentier, who showed that a guide-RNA sequence could direct the Cas9 enzyme to edit any chosen location in a genome with digital-style precision.
Digital genome design made possible the rapid creation of mRNA COVID-19 vaccines, with Moderna designing its candidate within days of the SARS-CoV-2 sequence being posted on January 10, 2020 and reaching first-in-human dosing by March 16, 2020.
DeepMind's AlphaFold2 won the CASP14 assessment in December 2020 and predicted protein structures directly from amino-acid sequences with near-experimental accuracy, demonstrating that machine learning could read biological information to solve a 50-year-old grand challenge.
The framing helped spawn the synthetic biology industry, in which DNA is written and ordered like code, supporting companies and tools that treat genetic sequences as programmable, version-controllable design files.
It grounds Kurzweil's documented projections, including his prediction (not established fact) that reverse-engineering the human brain will be achieved around 2029 and that biological and machine intelligence will merge in a technological Singularity he dates to 2045.

The Live Academic Debate

The central dispute concerns whether the Law of Accelerating Returns is a genuine law or selective extrapolation. Paul Allen and Mark Greaves, in "The Singularity Isn't Near" (MIT Technology Review, 2011), argued that a "complexity brake" governs the life sciences and neuroscience: deeper biological understanding does not yield Moore's-Law-style acceleration, and Kurzweil cherry-picks favorable curves. Kurzweil's rebuttal ("Don't Underestimate the Singularity," 2011) cited genomics—recalling that critics declared the genome project failing at 1% completion, not grasping that exponential doubling meant it was nearly done. Skeptics including Theodore Modis and Steven Pinker question whether disparate technologies can be aggregated onto a single exponential, while economists (Robert Gordon) note stagnant aggregate productivity despite digital advance. Historians of science such as Hallam Stevens (Life Out of Sequence, 2013) and Evelyn Fox Keller interrogate the "genome as information/code" metaphor itself, arguing it obscures biological materiality and overstates programmability—a critique that cuts against the very premise that biology straightforwardly "becomes" information technology.

The Counterfactual

Had the genomic cost curve not collapsed so steeply—had sequencing tracked only Moore's Law rather than vastly outpacing it after 2008's next-generation platforms—Kurzweil's strongest empirical exhibit would have weakened, and "biology as information technology" might have remained metaphor rather than apparent law. The technological driver here was contingent: Solexa/Illumina's massively parallel reversible-terminator chemistry, not Kurzweil's prediction, produced the inflection. Absent it, costs could have plateaued, vindicating critics like Paul Allen who argued a "complexity brake" governs the life sciences. Yet the deeper reframing was overdetermined: Watson and Crick's 1953 "code," GenBank (1982), and bioinformatics had already digitized biology. So even without Kurzweil, biology-as-information would have advanced—but the specific Singularitarian narrative, with its confident exponential extrapolation toward radical life extension and AGI timelines, depended heavily on the dramatic genomics curve. Without that curve, transhumanist forecasting would likely have been more hedged, and the cultural authority Kurzweil acquired—later joining Google in 2012—correspondingly diminished.

Myth vs. Reality

Myth: Kurzweil's claim that 'biology is now information technology' means we have understood the genome and can already reprogram our biology like software.

Reality: Sequencing a genome is not the same as understanding it. As critics including geneticist PZ Myers and biologists writing in Science have stressed, reading the DNA letters quickly does not grant an equally speedy understanding of what they mean. Traits are emergent properties of networks of interacting proteins, not one-to-one outputs of individual genes, and the 'missing heritability' problem (the gap between heritability estimated from pedigrees and that explained by discovered variants) has frustrated geneticists for over a decade. Kurzweil's framing of DNA as 'software' is a documented prediction/analogy about where biology is headed, not an accomplished fact.

Myth: The Human Genome Project (completed in 2003) sequenced the entire human genome.

Reality: The HGP and its follow-ups left roughly 8% of the genome unresolved, mostly in highly repetitive regions like centromeres and the short arms of acrocentric chromosomes. The first truly gapless, telomere-to-telomere human genome (T2T-CHM13) was not published until April 2022 by the T2T Consortium, adding nearly 200 million base pairs and ~2,000 gene predictions. Even that assembly initially lacked a complete Y chromosome. So 'the genome' people cite as finished in 2003 was a high-quality draft, not the complete sequence.

Myth: We achieved the '$1,000 genome,' so a fully sequenced and interpreted personal genome now costs about $1,000.

Reality: The widely cited $1,000 figure covers only sequencing consumables (reagents, chips) and excludes the sequencer, the technician, and—most importantly—analysis and clinical interpretation. Researchers dubbed this 'the $100,000 analysis' (Elaine Mardis) or even 'the $1-million interpretation' (Bruce Korf). Real-world clinical whole-genome sequencing, including counseling, bioinformatics, interpretation, and follow-up, has been estimated at roughly $3,000-$10,000 per patient. The headline number is, in the words of one critique, a 'bait and switch.'

Myth: DNA sequencing costs fell exponentially forever, vindicating Kurzweil's Law of Accelerating Returns at a steady pace.

Reality: Sequencing costs did fall dramatically—and from about 2008 to 2012 they dropped roughly 2,000 times faster than a Moore's Law baseline after next-generation sequencing arrived. But that super-exponential plunge was not permanent. NHGRI cost data show the curve flattened markedly after about 2015, with the rate of decline slowing well below its earlier pace. The trajectory is one of bursts driven by specific technology shifts, not a smooth perpetual exponential.

Myth: Kurzweil's track record proves these biotech predictions are about 86% accurate, so they should be treated as near-certainties.

Reality: The ~86% figure comes largely from Kurzweil grading his own predictions from 'The Age of Spiritual Machines,' a method critics consider too subjective because he selects which parts of vague statements to score as 'correct.' A LessWrong analysis ('good accuracy, poor self-calibration') found his self-ranking sits in roughly the 99th percentile of plausible scorings—i.e., generously self-favorable. His genome and biotechnology claims should be framed as documented projections from a self-described optimist, not as validated forecasts.

Frequently Asked Questions

What does Ray Kurzweil mean by 'biology becomes information technology'?

Kurzweil's argument, central to his 'law of accelerating returns,' is that once any field can be expressed as digital information, it begins improving at an exponential rate because each generation of tools helps design the next. He points to genomics: once DNA could be read and written as a digital code of base pairs processed by computers, biology became subject to the same exponential price-performance gains seen in computing. In his framing, the genome is the 'software' of life, and decoding and reprogramming it becomes an information-technology problem rather than a purely wet-lab one.

What was Kurzweil's point about the Human Genome Project being 'halfway done' at 1 percent?

Roughly halfway through the 15-year Human Genome Project, only about 1 percent of the genome had been sequenced, and many observers declared it a failure, reasoning it would take centuries to finish. Kurzweil argued the opposite: because sequencing output was doubling roughly every year, 1 percent was only about seven doublings from 100 percent, so the project was effectively halfway there in the terms that mattered. The project was indeed completed close to its target, finishing in April 2003. Kurzweil uses this repeatedly to illustrate how people mistake the early, flat part of an exponential curve for failure.

How much has the cost of sequencing a human genome actually fallen?

The Human Genome Project's first reference sequence, completed in 2003, cost on the order of hundreds of millions to billions of dollars across the full effort (the project's total was about $2.7 billion in FY 1991 dollars). The U.S. National Human Genome Research Institute, which tracks per-genome cost, documents a drop far faster than Moore's Law after 2007, when next-generation sequencing arrived. By the early 2020s the cost of sequencing a human genome had fallen to roughly $1,000 or less, a decline of several orders of magnitude that is often cited as evidence for Kurzweil's thesis.

Where does this idea appear in Kurzweil's work?

The concept is developed in Kurzweil's 2005 book 'The Singularity Is Near: When Humans Transcend Biology' and in his earlier essay 'The Law of Accelerating Returns' (2001). There he lays out the 'GNR' revolutions—Genetics, Nanotechnology, and Robotics (AI)—as overlapping waves that will transform the human condition. The genetics revolution, in his telling, is the point at which biology becomes an information technology we can read, debug, and rewrite. These are explicitly his projections and arguments, not settled scientific consensus.

Do scientists agree with Kurzweil's predictions about reprogramming biology?

Kurzweil's track record on the exponential decline in sequencing cost is widely acknowledged, and the digitization of genomics is real. However, his broader predictions—that we will soon reverse aging, eliminate most disease through gene therapies, and merge biology with nanotechnology on his stated timelines—remain contested projections rather than established outcomes. Critics, including some biologists and commentators in venues like Science, argue that biology's complexity (gene regulation, protein folding, multi-system interactions) does not reduce as cleanly to an information-technology exponential as raw sequencing cost does. These claims should be read as documented forecasts, not facts.

Why does Kurzweil treat genome sequencing as proof of the law of accelerating returns?

For Kurzweil, sequencing is a clean case study because it converts a biological process into a measurable, digital one whose cost and throughput can be charted over time. The roughly annual doubling in sequencing capacity during the Human Genome Project, and the steep post-2007 cost collapse, fit the smooth exponential curve his law predicts. He uses it to make a general claim: that once a technology becomes informational, linear intuition badly underestimates future progress. Whether that pattern generalizes to curing aging or building molecular nanobots is a separate, still-open question.